Technology research and development of guilin sanjin Pharmaceutical Co., Ltd.

Technology Center: it is the technical management and new product research and development institution of Sanjin Pharmaceutical. After several years of development and improvement, Sanjin Pharmaceutical Technology Center has become a modern enterprise technology center with complete functional supporting system, reasonable structure and advanced facilities, including two platforms of new drug development and industrialization research and related functional management departments. Under the direct leadership of the person in charge of the enterprise, the Technology Center has developed two Chinese medicine brands, namely, watermelon frost series with three gold medals and Sanjin tablets series. Watermelon frost series products are listed as protected varieties by the General Administration of Quality Inspection and Quarantine. In December 21, Sanjin Pharmaceutical Technology Center was officially recognized as a national enterprise technology center after strict qualification examination by the State Economic and Trade Commission and the Enterprise Technology Evaluation Center of Chinese Academy of Sciences. In the same year, it was authorized by the Ministry of Personnel to establish the enterprise Post-Doctoral Research Center. The technical center consists of three functional organizations: the central office, the production technology department and the drug research institute.

pharmaceutical research institute: it consists of drug screening research center, natural medicine research center, modern Chinese medicine new drug research center and preparation research center. Multidisciplinary personnel, complete professional categories, strong technical force, rich experience and strong development ability in technological innovation.

The functions of the Institute of Pharmacology are as follows: 1. Applying modern technical means, combining traditional Chinese medicine theory and based on the resources of Chinese herbal medicine in Guangxi, developing modern Chinese medicine with independent intellectual property rights. 2. Second innovation of the company's old products. Through the re-study of the process improvement and quality standard improvement of old products, the technical content and market competitiveness of old products can be improved. 3. Conduct basic research on listed varieties to provide technical support for the market. 4. Devote to the research on extraction, separation, qualitative and quantitative analysis of effective components of traditional Chinese medicine, and develop natural medicines with independent intellectual property rights. 5, to carry out new technology, new dosage form research. 6, to carry out drug screening, provide experimental basis for new drug development, and point out the direction for new drug research. 7. Carry out research on resources of traditional Chinese medicine with Guangxi characteristics, and guide the construction of GAP base.

The new scientific research building with an investment of 35 million yuan can be engaged in the research of tablets, capsules, powders, pills, granules, dripping pills, suppositories, injections, soft capsules and other preparations; Supercritical extraction, macroporous resin separation, membrane separation, freeze-drying, ultrasonic extraction, ultra-fine (airflow) crushing and other technological research; The advanced detection instruments are: WATERS HPLC, SP HPLC, HP and PE GC, Kama SCANNER3 thin-layer scanner, PE atomic absorption spectrophotometer, etc.

in order to gain a long-term competitive advantage, the company has determined the medium-and long-term planning and development strategy of the enterprise. The medium-and long-term planning is as follows: to establish a leading domestic and international first-class manufacturer of traditional Chinese medicine and natural medicine; The development strategy is: adhere to the guidance of traditional Chinese medicine theory, take modern science and technology as the means, and rely on the rich Chinese herbal medicine and Zhuang minority medical resources in Guangxi to develop modern Chinese patent medicines with independent intellectual property rights, which are safe, effective, controllable in quality, blank or scarce in the market. On the basis of medium-and long-term planning of enterprises, the innovative development plan combining science and technology with economy has been formulated, forming a three-gold "four-dimensional" echelon technology development strategy, and the research and development of new products has formed a virtuous circle of "producing a batch, storing a batch, developing a batch and conceiving a batch"; The development of old products has formed a pattern of "producing one generation, taking one generation, researching one generation and thinking about one generation"; Production and development show the trend of "sowing a batch of seeds, selecting a batch of seedlings and cultivating a batch of wood", and technical development forms a multi-level structure combining traditional technology, general technology and advanced high technology. According to the current situation at home and abroad and the enterprise's own situation, the Technology Center has continuously improved the enterprise's technology innovation strategy, and put forward that the technology innovation strategy takes the research and development of traditional Chinese medicine and natural medicine as the main direction of technology innovation, biological medicine, functional health food and daily chemical products as the auxiliary innovation direction, and takes the technology center as the platform, from basic technology and technology to product innovation, so as to continuously improve the enterprise's originality and scientific and technological content, and finally improve its core competitiveness.